Business Description
Sera Prognostics Inc
NAICS : 325413
SIC : 5047
ISIN : US81749D1072
Share Class Description:
SERA: Class ATotal Employee Number:
72Description
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 18.92 | |||||
Equity-to-Asset | 0.72 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.08 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -3.73 | |||||
Beneish M-Score | -4.29 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -39.4 | |||||
3-Year EBITDA Growth Rate | 22.6 | |||||
3-Year EPS without NRI Growth Rate | 22.7 | |||||
3-Year FCF Growth Rate | 21.5 | |||||
3-Year Book Growth Rate | -15.3 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 13.4 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 414.21 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 44.56 | |||||
9-Day RSI | 49.16 | |||||
14-Day RSI | 50.67 | |||||
3-1 Month Momentum % | -10.45 | |||||
6-1 Month Momentum % | -44.44 | |||||
12-1 Month Momentum % | -44.62 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.12 | |||||
Quick Ratio | 2.12 | |||||
Cash Ratio | 2.02 | |||||
Days Sales Outstanding | 101.18 | |||||
Days Payable | 2170.65 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7.9 | |||||
Shareholder Yield % | -1.18 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -191.23 | |||||
Operating Margin % | -64235.09 | |||||
Net Margin % | -56385.97 | |||||
EBITDA Margin % | -54764.91 | |||||
FCF Margin % | -48377.19 | |||||
OCF Margin % | -47094.74 | |||||
ROE % | -39.37 | |||||
ROA % | -30.12 | |||||
ROIC % | -43.25 | |||||
3-Year ROIIC % | 20.2 | |||||
ROC (Joel Greenblatt) % | -2773.43 | |||||
ROCE % | -38.67 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1025 | |||||
PB Ratio | 1.19 | |||||
Price-to-Tangible-Book | 1.2 | |||||
EV-to-EBIT | -1.1 | |||||
EV-to-EBITDA | -1.13 | |||||
EV-to-Revenue | 620.68 | |||||
EV-to-Forward-Revenue | 36.49 | |||||
EV-to-FCF | -1.28 | |||||
Price-to-GF-Value | 1.12 | |||||
| Price-to-Net-Current-Asset-Value | 3.36 | |||||
| Price-to-Net-Cash | 3.73 | |||||
Earnings Yield (Greenblatt) % | -90.91 | |||||
FCF Yield % | -34.35 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SERA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sera Prognostics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.057 | ||
| EPS (TTM) ($) | -0.65 | ||
| Beta | 2.1383 | ||
| 3-Year Sharpe Ratio | 0.28 | ||
| 3-Year Sortino Ratio | 0.73 | ||
| Volatility % | 36.6 | ||
| 14-Day RSI | 50.67 | ||
| 14-Day ATR ($) | 0.189882 | ||
| 20-Day SMA ($) | 2.031 | ||
| 12-1 Month Momentum % | -44.62 | ||
| 52-Week Range ($) | 1.56 - 3.95 | ||
| Shares Outstanding (Mil) | 39.16 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sera Prognostics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sera Prognostics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-13 17:00 | In 111 days | ||
| Third quarter earnings results for 2026 | 2026-11-13 | In 110 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-06 17:00 | In 12 days | ||
| Second quarter earnings results for 2026 | 2026-08-06 | In 11 days | ||
| General meeting for 2026 | 2026-06-04 09:00 | 2.05 (-0.49%) | ||
| First quarter earnings conference call for 2026 | 2026-05-06 17:00 | 1.88 (-2.08%) | ||
| First quarter earnings results for 2026 | 2026-05-06 | 1.88 (-2.08%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-18 17:00 | 2.01 (-1.99%) | ||
| Annual report for 2025 | 2026-03-18 | 2.01 (-1.99%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-18 | 2.01 (-1.99%) |
Show
Entries
Sera Prognostics Inc Frequently Asked Questions
What is Sera Prognostics Inc(SERA)'s stock price today?
The current price of SERA is $2.05. The 52 week high of SERA is $3.95 and 52 week low is $1.56.
When is next earnings date of Sera Prognostics Inc(SERA)?
The next earnings date of Sera Prognostics Inc(SERA) is 2026-08-06 Est..
Does Sera Prognostics Inc(SERA) pay dividends? If so, how much?
Sera Prognostics Inc(SERA) does not pay dividend.
Guru Commentaries on NAS:SERA
No articles.
Press Release
Articles on Sera Prognostics Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers